| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/31/2003 | WO2002012286A3 Stress proteins and peptides and methods of use thereof |
| 07/31/2003 | US20030144473 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 07/31/2003 | US20030144472 Method of identifying designable protein backbone configurations |
| 07/31/2003 | US20030144230 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation |
| 07/31/2003 | US20030144211 Inhibit leukocyte adhesion to endothelium or to platelets |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030144186 Conformationally constrained backbone cyclized peptide analogs |
| 07/31/2003 | US20030144185 Nanotube structures formed from a plurality of stacked cyclic peptides comprising chromophore residues that provide molecular scale electronic conductivity and non linear optical behavior |
| 07/31/2003 | US20030144184 Nonhemolytic, exhibit minimal in vitro cytotoxicity; treatment of bacterial and/or viral infection, especially one caused by HIV-1 retrovirus or other sexually-transmitted pathogens |
| 07/31/2003 | US20030144183 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 07/31/2003 | US20030143750 Peptide compounds, method of measuring sulfur compound and ammonia therewith, and measuring device using the same |
| 07/31/2003 | US20030143692 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 07/31/2003 | US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes |
| 07/31/2003 | US20030143661 Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 07/31/2003 | US20030143651 Fret protease assays for clostridial toxins |
| 07/31/2003 | US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis |
| 07/31/2003 | US20030143158 For diagnosis and therapy of pathological intravascular thrombosis; for detecting, imaging, and localizing thrombi |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2473032A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 07/31/2003 | CA2472775A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 07/30/2003 | EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 07/30/2003 | EP1330264A2 Vaccine for treating allergy |
| 07/30/2003 | EP0956292A4 Conantokins |
| 07/30/2003 | EP0702696B1 Trifunctional antithrombin and antiplatelet peptides |
| 07/30/2003 | CN1433429A Oligopeptides |
| 07/30/2003 | CN1116305C Peptide derivatives |
| 07/30/2003 | CN1116304C Organic compound |
| 07/29/2003 | US6600031 Methods of making nucleic acid or oligonucleotide arrays |
| 07/29/2003 | US6600015 Treatment or prevention of obesity. |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | CA2078379C Method of treating immunoinflammatory disease |
| 07/29/2003 | CA2069724C Process for making peptides containing aza-amino acids |
| 07/24/2003 | WO2003060522A1 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003059943A2 Conformation-specific, protein kinase binding peptides and related methods and products |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells |
| 07/24/2003 | WO2003059937A2 Synthetic ion channels |
| 07/24/2003 | WO2003059933A2 Conformationally constrained c-backbone cyclic peptides |
| 07/24/2003 | WO2003059436A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002062961A3 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | US20030139345 Synthetic peptides and methods for treating cancer invasion and metastasis |
| 07/24/2003 | US20030139326 Antiinflammatory agents; autoimmune disease |
| 07/24/2003 | US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 07/24/2003 | US20030138894 Angiotensin converting enzyme-2/like polypeptides and inhibitors for treating and/or prevention of hypertension, congestive heart failure, stroke and atherosclerotic heart disease |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138854 Method for determining BAGE expression |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138388 Artificial tanning |
| 07/24/2003 | CA2473229A1 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/24/2003 | CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/23/2003 | EP1328658A2 Recombination modulators and methods for their production and use |
| 07/23/2003 | EP1328546A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 07/23/2003 | EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis |
| 07/23/2003 | EP1011716B1 Neuromedin b receptor antagonists |
| 07/23/2003 | EP0956033B1 Total synthesis of the amino hip analogue of didemnin a |
| 07/23/2003 | EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 07/23/2003 | CN1432024A Immunodominant acetylcholine receptor alpha subunit peptides |
| 07/23/2003 | CN1432022A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/22/2003 | USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 07/22/2003 | US6596692 Substance P analogs for the treatment of cancer |
| 07/22/2003 | US6596687 Cell adhesion inhibitors |
| 07/22/2003 | US6596498 Bone stimulating factor |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057724A1 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 07/17/2003 | WO2003057723A2 Fluorogenic protease substrates doubly labelled with rhodamine moieties |
| 07/17/2003 | WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | WO2003057134A2 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | WO2002081646A3 Epitope sequences |
| 07/17/2003 | WO2002058589A3 Agents and methods for promoting bone growth |
| 07/17/2003 | WO2002039947A3 Carrier vectors through an epithelium with tight junctions |
| 07/17/2003 | US20030135026 Compounds and methods for diagnosis of tuberculosis |
| 07/17/2003 | US20030135024 Volatilizable solid phase supports for compound synthesis |
| 07/17/2003 | US20030135023 Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 07/17/2003 | US20030134889 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/17/2003 | US20030134800 Physiologically active substance in high content, suppressing the initial excess release, and achieving a stable release speed over a long period of time is provided. composition weight, (2) hydroxynaphthoic acid |
| 07/17/2003 | US20030134342 Binding-specific peptides, binding-specific carrier molecules, and uses thereof |
| 07/17/2003 | US20030133927 Conjugates useful in the treatment of prostate cancer |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2472617A1 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 07/17/2003 | CA2471458A1 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 07/16/2003 | EP1327146A2 Compounds with a branched linker |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326883A1 Antisense peptides to human fc receptors and their uses |